Is a complete ADVB research report available?

No complete published report is available for Advanced Biomed Inc. (ADVB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Advanced Biomed Inc. (ADVB)

NASDAQ: ADVB · USD

$2.93

-0.11 (-3.6%)· Recorded snapshot

Market cap	4.8M
Revenue (ttm)	127.6K
Net income (ttm)	6.7M
EPS (ttm)	$5.33
Shares out	1.7M
P/E (trailing)	0.5x
Volume	17,255

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 127.6K
Net income (ttm): 6.7M
EPS (ttm): $5.33
P/E (trailing): 0.5x
Market cap: 4.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001941029
Company name	Advanced Biomed Inc.
Country	Hong Kong
Country code	US
CUSIP number	00752P203
Earnings date	2026-11-18
Earnings time	amc
Employees	12
Employees change	-19
Employees growth	-61.29%
Enterprise value	$5.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	2014
Industry	Diagnostics & Research
IPO date	2025-03-06
Is primary listing	Yes
Is SPAC	No
ISIN number	US00752P2039
Last 10-K release date	2026-10-13
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Last stock split date	2026-02-20
Last stock split type	Reverse
Market cap	$4.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-18
Options	No
Price	$2.93
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	ADVB
Website	https://www.advb.ai

Metric

Value

Amount currency

USD

CIK code

0001941029

Company name

Advanced Biomed Inc.

Country

Hong Kong

Country code

CUSIP number

00752P203

Earnings date

2026-11-18

Earnings time

amc

Employees

Employees change

-19

Employees growth

-61.29%

Enterprise value

$5.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

June

Founded

2014

Industry

Diagnostics & Research

IPO date

2025-03-06

Is primary listing

Yes

Is SPAC

ISIN number

US00752P2039

Last 10-K release date

2026-10-13

Last earnings date

2026-10-13

Last refreshed

2026-10-28

Last stock split date

2026-02-20

Last stock split type

Reverse

Market cap

$4.8M

Market cap category

Nano-Cap

Next earnings date

2026-11-18

Options

Price

$2.93

Price currency

USD

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

ADVB

Website

https://www.advb.ai

Metric	Value
Earnings yield	181.91%
EV/Earnings	0.83x
EV/Sales	43.35x
FCF / EV yield	-35.19%
FCF yield	-40.22%
Graham number	29.85211
Graham upside	918.84%
Industry forward P/E	30.87x
Industry P/E	50.24x
P/B ratio	0.41x
P/E ratio	0.55x
P/S ratio	37.93x
Price / tangible book value	0.39x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

181.91%

EV/Earnings

0.83x

EV/Sales

43.35x

FCF / EV yield

-35.19%

FCF yield

-40.22%

Graham number

29.85211

Graham upside

918.84%

Industry forward P/E

30.87x

Industry P/E

50.24x

P/B ratio

0.41x

P/E ratio

0.55x

P/S ratio

37.93x

Price / tangible book value

0.39x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	100%
Operating margin	-4,883.8%
Pretax margin	-4,906.48%
Profit margin	5,231.3%
Profit per employee	$556,423
Profitable quarters	1
Profitable years	1
Revenue per employee	$10,636
ROA	-21.28%
ROA (5Y)	-26.74%
ROCE	-50.78%
ROE	-79.49%
ROE (5Y)	-129.02%
ROIC	-46.29%
SBC / revenue	1,358.55%
Tax / revenue	-0.94%

Metric

Value

Gross margin

100%

Operating margin

-4,883.8%

Pretax margin

-4,906.48%

Profit margin

5,231.3%

Profit per employee

$556,423

Profitable quarters

Profitable years

Revenue per employee

$10,636

ROA

-21.28%

ROA (5Y)

-26.74%

ROCE

-50.78%

ROE

-79.49%

ROE (5Y)

-129.02%

ROIC

-46.29%

SBC / revenue

1,358.55%

Tax / revenue

-0.94%

Metric	Value
EPS growth quarters	3
EPS growth years	1
Net income growth quarters	3
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$59,281
EBIT	$-6.2M
EBITDA	$-6.2M
EPS	$5.33
FCF per share	$-1.18
Financing cash flow	$2M
Free cash flow	$-1.9M
Free cash flow minus SBC	$-3.7M
Gross profit	$127,637
Income taxes	$-1,205
Investing cash flow	$-2.5M
Net borrowing	$1.1M
Net cash flow	$-2.5M
Net income	$6.7M
Operating cash flow minus SBC	$-3.7M
Operating income	$-6.2M
Revenue	$127,637
Stock-based compensation	$1.7M

Metric

Value

Depreciation and amortization

$59,281

EBIT

$-6.2M

EBITDA

$-6.2M

EPS

$5.33

FCF per share

$-1.18

Financing cash flow

$2M

Free cash flow

$-1.9M

Free cash flow minus SBC

$-3.7M

Gross profit

$127,637

Income taxes

$-1,205

Investing cash flow

$-2.5M

Net borrowing

$1.1M

Net cash flow

$-2.5M

Net income

$6.7M

Operating cash flow minus SBC

$-3.7M

Operating income

$-6.2M

Revenue

$127,637

Stock-based compensation

$1.7M

Metric	Value
Altman Z-Score	1.82
Book value per share	$7.43
Debt / equity	0.09
Interest coverage	-888.73
Long-term assets	$1,204
Long-term liabilities	$0
Net cash (debt)	$-692,680
Net cash / market cap	-14.31%
Net debt / equity	0.06
Piotroski F-Score	2
Shareholders' equity	$12.3M
Tangible book value	$12.3M
Tangible book value per share	$7.43
Total assets	$13.8M
Total cash	$385,535
Total debt	$1.1M
Total liabilities	$1.5M

Metric

Value

Altman Z-Score

1.82

Book value per share

$7.43

Debt / equity

0.09

Interest coverage

-888.73

Long-term assets

$1,204

Long-term liabilities

Net cash (debt)

$-692,680

Net cash / market cap

-14.31%

Net debt / equity

0.06

Piotroski F-Score

Shareholders' equity

$12.3M

Tangible book value

$12.3M

Tangible book value per share

$7.43

Total assets

$13.8M

Total cash

$385,535

Total debt

$1.1M

Total liabilities

$1.5M

Metric	Value
Asset turnover	0.01
Current assets	$13.7M
Current liabilities	$1.5M
Current ratio	9.33
Net working capital	$13M
Quick ratio	9.33
Working capital	$12.3M
Working capital turnover	0.02

Metric

Value

Asset turnover

0.01

Current assets

$13.7M

Current liabilities

$1.5M

Current ratio

9.33

Net working capital

$13M

Quick ratio

9.33

Working capital

$12.3M

Working capital turnover

0.02

Metric	Value
Buyback yield / dilution	-22.06%
Dividend yield	0%
Shareholder yield	-22.06%

Metric

Value

Buyback yield / dilution

-22.06%

Dividend yield

Shareholder yield

-22.06%

Metric	Value
150-day SMA	$6.27
1D price change	-3.62%
1M price change	-54.08%
1M total return	-54.08%
1W price change	-22.07%
1W total return	-22.07%
1Y price change	-67.46%
1Y return CAGR	-67.48%
1Y total return	-67.46%
20-day SMA	$4.77
200-day SMA	$5.96
3M price change	-79.6%
3M total return	-79.6%
50-day SMA	$6.75
50-day SMA vs 200-day SMA	50over200
52-week high	$24.23
52-week high date	2026-07-24
52-week low	$2.71
52-week low date	2026-10-27
6M price change	-44.72%
6M total return	-44.72%
All-time high	$82.00
All-time high date	2025-03-06
All-time low	$2.71
All-time low date	2026-10-27
Average true range (ATR)	$0.60
Average volume	38K
Beta (1Y)	0.79
Beta (2Y)	0.5
Change from 52-week high	-87.91%
Change from 52-week low	8.12%
Change from all-time high	-96.43%
Change from all-time low	8.12%
Change from open	-2.66%
Day's gap	-0.99%
Dollar volume	$50,557
High price	$3.06
Low price	$2.93
Monthly RSI	9.23
Open price	$3.01
Position in 52-week range	0%
Premarket change	0.33%
Premarket close	$3.04
Premarket price	$3.05
Previous close	$3.04
Price vs 150-day SMA	-53.29%
Price vs 20-day SMA	-38.63%
Price vs 200-day SMA	-50.87%
Price vs 50-day SMA	-56.57%
Relative volume	0.46
Return from IPO open	-96.34%
Return from IPO price	-26.75%
RSI	23.8
Sharpe ratio	0.04
Sortino ratio	0.12
Volume	17.3K
Weekly RSI	40.7
YTD price change	-49.79%
YTD total return	-49.79%

Metric

Value

150-day SMA

$6.27

1D price change

-3.62%

1M price change

-54.08%

1M total return

-54.08%

1W price change

-22.07%

1W total return

-22.07%

1Y price change

-67.46%

1Y return CAGR

-67.48%

1Y total return

-67.46%

20-day SMA

$4.77

200-day SMA

$5.96

3M price change

-79.6%

3M total return

-79.6%

50-day SMA

$6.75

50-day SMA vs 200-day SMA

50over200

52-week high

$24.23

52-week high date

2026-07-24

52-week low

$2.71

52-week low date

2026-10-27

6M price change

-44.72%

6M total return

-44.72%

All-time high

$82.00

All-time high date

2025-03-06

All-time low

$2.71

All-time low date

2026-10-27

Average true range (ATR)

$0.60

Average volume

38K

Beta (1Y)

0.79

Beta (2Y)

0.5

Change from 52-week high

-87.91%

Change from 52-week low

8.12%

Change from all-time high

-96.43%

Change from all-time low

8.12%

Change from open

-2.66%

Day's gap

-0.99%

Dollar volume

$50,557

High price

$3.06

Low price

$2.93

Monthly RSI

9.23

Open price

$3.01

Position in 52-week range

Premarket change

0.33%

Premarket close

$3.04

Premarket price

$3.05

Previous close

$3.04

Price vs 150-day SMA

-53.29%

Price vs 20-day SMA

-38.63%

Price vs 200-day SMA

-50.87%

Price vs 50-day SMA

-56.57%

Relative volume

0.46

Return from IPO open

-96.34%

Return from IPO price

-26.75%

RSI

23.8

Sharpe ratio

0.04

Sortino ratio

0.12

Volume

17.3K

Weekly RSI

40.7

YTD price change

-49.79%

YTD total return

-49.79%

Metric	Value
Float	677.1K
Float percentage	40.98%
Shares change (QoQ)	21.79%
Shares change (YoY)	22.06%
Shares held by insiders	52.41%
Shares held by institutions	0.06%
Shares outstanding	1.7M
Short % of float	2.79%
Short % of shares	1.14%
Short ratio	0.3 days

Metric

Value

Float

677.1K

Float percentage

40.98%

Shares change (QoQ)

21.79%

Shares change (YoY)

22.06%

Shares held by insiders

52.41%

Shares held by institutions

0.06%

Shares outstanding

1.7M

Short % of float

2.79%

Short % of shares

1.14%

Short ratio

0.3 days

Advanced Biomed Inc. (ADVB)

Price

Financial snapshot

Fair-value bridge

Latest news · ADVB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADVB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADVB

Frequently asked questions